Infectious Diseases Society of America

...five years than in the previous 20, notes Dr. William Schaffner, Vanderbilt University's head of preventive medicine and a spokesman for the Infectious Diseases Society of America. Please keep your comments respectful of others by avoiding...

In this article: Alzheimer's disease, Johnson & Johnson, U.S., C. difficile, Dengue fever, Cocaine, Cervical cancer, Allergy, AIDS, and Nicotine

...run by the Centers for Disease Control and Prevention. The drug is then sent overnight from a central stockpile," the newspaper writes. "If you have a critically ill patient, to delay therapy, it's just incomprehensible to me," said Richard...

In this article: Influenza, Peramivir, Relenza, Medical advice, Keiji Fukuda, Influenza vaccine, and Los Angeles Times

Originally published Thursday, November 19, 2009 at 12:17 AM A shot in the arm for drugmakers Vaccines now are viewed as a crucial path to growth, as drugmakers look for ways to bolster slowing prescription medicine sales amid...

In this article: GlaxoSmithKline, Alzheimer's, U.S., Cervical cancer, Meningitis, Rotavirus, Wyeth, Johnson & Johnson, Pfizer, and Merck

Article Date: 30 Oct 2009 - 5:00 PDT The Phoenix-based non-profit Translational Genomics Research Institute (TGen) has announced that, along with a business collaborator, it will submit a request to the U.S. Food and Drug Administration...

In this article: H1N1, Influenza, Oseltamivir, FDA, and Flagstaff

By LINDA A. JOHNSON, AP Business Writer Linda A. Johnson, Ap Business Writer - 24 mins ago Many could be on the market in five years or less. Contrast that with five years ago, when so many companies had abandoned the vaccine business...

In this article: FLU, Alzheimer's, GlaxoSmithKline, AIDS, U.S., Johnson & Johnson, Cervical cancer, Meningitis, Rotavirus, and Wyeth